Patents by Inventor Amy L. Finkenaur

Amy L. Finkenaur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gel formulations containing growth factors
    Patent number: 5457093
    Abstract: Gel formulations containing polypeptide growth factors having human mitogenic or angiogenic activity are provided. The gel formulations are useful for topical or incisional wound healing for cutaneous wounds, in the anterior chamber of the eye and other ophthalmic wound healing. The gel formulations also comprise a water soluble, pharmaceutically or ophthalmically compatible polymeric material for providing viscosity within various ranges determined by the application of the gel. The gel formulations provide controlled release and increased contact time of the growth factor to the wound site.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: October 10, 1995
    Assignee: Ethicon, Inc.
    Inventors: John K. Cini, Amy L. Finkenaur
  • Gel formulations containing growth factors and acrylamide polymer
    Patent number: 5427778
    Abstract: Gel formulations containing polypeptide growth factors having human mitogenic or angiogenic activity are provided. The gel formulations are useful for topical or incisional wound healing for cutaneous wounds, in the anterior chamber of the eye and other ophthalmic wound healing. The gel formulations also comprise a water soluble, pharmaceutically or ophthalmically compatible polymeric material for providing viscosity within various ranges determined by the application of the gel. The gel formulations provide controlled release and increased contact time of the growth factor to the wound site.
    Type: Grant
    Filed: November 10, 1992
    Date of Patent: June 27, 1995
    Assignee: Ethicon, Inc.
    Inventors: Amy L. Finkenaur, Jonathan M. Cohen, Shalaby W. Shalaby, Elisabeth A. Sandoval, Rao S. Bezwada, Richard L. Kronenthal
  • Stabilized compositions containing epidermal growth factor
    Patent number: 5130298
    Abstract: The present invention provides a pharmaceutical composition comprising a pharmaceutically effective amount of human epidermal growth factor (EGF) and an amount of a pharmaceutically acceptable metal cation, such as zinc, which is sufficient to prevent the degradation of said EGF.
    Type: Grant
    Filed: May 16, 1989
    Date of Patent: July 14, 1992
    Assignee: Ethicon, Inc.
    Inventors: John K. Cini, Amy L. Finkenaur
  • Stabilized compositions containing epidermal growth factor
    Patent number: 4717717
    Abstract: Medicinal compositions containing epidermal growth factor are stabilized against loss of biological activity in the presence of moisture by including in said compositions a stabilizing amount of water-soluble cellulose polymer, preferably methylcellulose or a hydroxy alkylcellulose such as hydroxypropyl methylcellulose.
    Type: Grant
    Filed: November 5, 1986
    Date of Patent: January 5, 1988
    Assignee: Ethicon, Inc.
    Inventor: Amy L. Finkenaur